ENFORTUMAB VEDOTIN

7224 reported adverse events

These side effects are most commonly reported by patients taking ENFORTUMAB VEDOTIN:

# Side effect Count
0 RASH 945
1 NEUROPATHY PERIPHERAL 852
2 MALIGNANT NEOPLASM PROGRESSION 837
3 DIARRHOEA 468
4 PRURITUS 419
5 FATIGUE 404
6 DEATH 400
7 DECREASED APPETITE 396
8 OFF LABEL USE 358
9 ALOPECIA 307
See all common reactions for ENFORTUMAB VEDOTIN

ENFORTUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSITIONAL CELL CARCINOMA METASTATIC 37 0.3364
1 MICROCOCCAL SEPSIS 4 0.2000
2 TRANSITIONAL CELL CARCINOMA RECURRENT 8 0.1702
3 PLEURISY BACTERIAL 6 0.1579
4 URINARY BLADDER HAEMATOMA 3 0.1154
5 BLADDER DYSPLASIA 2 0.1111
6 URINARY BLADDER ATROPHY 4 0.0870
7 TOXIC ERYTHEMA OF CHEMOTHERAPY 19 0.0809
8 KL-6 INCREASED 14 0.0664
9 UROSTOMY COMPLICATION 3 0.0652
See all enriched reactions for ENFORTUMAB VEDOTIN